RSI & Associates, Inc. Announces Limited Use of Artificial Intelligence (AI) in Business Valuations
CORPUS CHRISTI, Texas, June 10, 2025 (SEND2PRESS NEWSWIRE) — RSI & Associates, Inc., a leading provider of business valuation, feasibility studies and consulting services, today announced a policy of limited and careful application of Artificial Intelligence (AI) in the preparation and analysis of business valuations. This decision is driven by the firm's commitment to maintaining the highest standards of accuracy, reliability, and ethical conduct in its valuation practice, particularly in light of current legal, regulatory, and ethical uncertainties surrounding the use of AI in financial analysis.
While recognizing the potential of AI to enhance certain aspects of business valuation, RSI & Associates acknowledges the inherent risks and limitations associated with AI's current state of development.
These include concerns about:
RSI & Associates emphasizes that the core of its business valuation methodology will continue to rely on the expertise and professional judgment of its accredited valuation analysts. These professionals possess the critical thinking skills and industry knowledge necessary to interpret complex data, identify nuanced value drivers, and provide well-supported, defensible valuation opinions. This human element represents the 'Art' aspect of Business Valuations.
According to Gerald W. Brown, Sr, President and Senior Business Appraiser at RSI & Associates, 'Accurate and reliable valuations depend on the expertise of the appraiser, as the integrity of the valuations must be a priority. Valuations, whether of a company's stock or from an asset sale perspective, rely on both 'science' and 'art.' AI can certainly assist with the scientific aspects by processing large datasets and applying algorithms. However, it cannot replace the 'Art' demonstrated through human judgment, stakeholder interaction, subjective assessment and qualitative analysis, which are all crucial for a defensible outcome of a certified valuation.'
About RSI:
Founded in 1993, RSI & Associates, Inc. has provided business valuation, feasibility studies, exit planning and consulting services for over 30 years. RSI & Associates serves clients across the United States, in diverse industries, offering comprehensive and objective valuation opinions for a wide range of purposes. RSI & Associates, Inc. is committed to maintaining the highest standards of integrity, professionalism, and client service in every engagement.
Learn more at: https://rsivalue.com/
LOGO link for media: https://www.Send2Press.com/300dpi/25-0610-s2p-rsiassoc-300dpi.jpg
NEWS SOURCE: RSI & Associates Inc.
Keywords: Consulting and Coaching, business valuation, feasibility studies and consulting services, AI, Artificial Intelligence, SBA Loans, USDA Loans, Feasibility Stud, CORPUS CHRISTI, Texas
This press release was issued on behalf of the news source (RSI & Associates Inc.) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P126829 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/rsi-associates-inc-announces-limited-use-of-artificial-intelligence-ai-in-business-valuations/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Factbox-Breakdown of U.S. tariffs on China since Trump's first term
BEIJING (Reuters) -Billions of dollars of Chinese goods have been impacted by additional U.S. tariffs since 2018, initially under the first Donald Trump presidency and later under the Biden administration. Returning to the White House this year, Trump has imposed even more duties on China. The U.S. tariffs range from those imposed under Section 301 of its trade act due to what Washington claims are unfair Chinese trade practices, to duties under Section 232 levied for national security reasons. This year, Trump has imposed another 20% levies on all Chinese goods, saying Beijing has not done enough to stop the flow of fentanyl into the United States. So-called reciprocal tariffs, under which the U.S. will match duties imposed by other countries, have also been levied in a bid to rebalance trade flows. Below are the U.S. tariffs on China effective as of June 12, 2025: Tariff Rate Products Effective date Reciprocal 10% All Paused for 90 days until Aug 10, 2025 Fentanyl 20% All Mar 4, 2025 Section Up to List 1: Pharmaceuticals, July 6, 2018 301 25% iron and steel, aluminium, vehicles and aircraft, medical or surgical instruments and apparatus and more. List 2: Vehicles, Aug 23, 2018 railway or tramway locomotives, aircraft and their parts, medical or surgical instruments and apparatus and more. List 3: Prepared May 10, 2019 foodstuffs, beverages, mineral products, fertilizers, wood products, textiles, precious and base metals, vehicles, aircraft, vessels, machinery and mechanical appliances and more. List 4A: Prepared Feb 14, 2020 foodstuffs, beverages, mineral products, fertilizers, footwear, wood products, ceramic products, glass, textiles, precious and base metals, machinery and mechanical appliances, vehicles, aircraft, vessels, art, antiques and more. In September 2019, the U.S. imposed 15% tariffs on more than $120 billion of Chinese goods under Section 301, which it then halved to 7.5% less than six months later. The 25% U.S. tariffs on $250 billion of Chinese goods under the earlier List 1-3 remain unchanged. In September 2024, the U.S. Trade Representative under the Biden administration announced additional tariffs of 25-100% on 14 product groups following a four-year review of the Section 301 tariff actions. The levies were imposed on strategic Chinese sectors or sectors where the United States has made significant domestic investments. Additional tariffs on goods under Section 301: Effective date EVs 100% Sep 27, 2024 Solar cells, syringes and 50% needles Non-lithium-ion battery parts, 25% lithium-ion electrical vehicle batteries, other critical minerals, ship-to-shore cranes, steel and aluminium products, facemasks Semiconductors 50% Jan 1, 2025 Lithium-ion non-electrical 25% Jan 1, 2026 vehicle batteries, medical gloves, natural graphite, permanent magnets In addition to the above duties, the first Trump administration in 2018 imposed a range of tariffs under Section 232 aimed at restricting goods deemed a threat to national security, including all aluminium and steel imports, shutting most Chinese suppliers out of the U.S. market. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
XRP Consolidates Near $2.28 Amid Slew of Wins for Ripple, XRPL
XRP XRP traded in a narrow range over the past 24 hours, consolidating between $2.27 and $2.32 as global trade tensions and diverging central bank policies weighed on investor sentiment. The digital asset demonstrated resilience amid broader market volatility, with strong buying interest emerging at key support levels. News Background Ripple's regulatory wins in Dubai and progress on stablecoin initiatives, such as RLUSD, provide a fundamental tailwind, though traders remain wary amid volatile global conditions. Ondo Finance's Ondo Short-Term U.S. Government Treasuries (OUSG) is now live on the XRP Ledger (XRPL), expanding institutional access to the institutional-grade RWA product onchain. Digital Commercial Paper (DCP), secured by U.S. Treasuries, is now live on the XRP Ledger, enhancing efficiency and accessibility. Administered by Guggenheim Treasury Services, DCP is tokenized and managed through the Zeconomy platform, offering custom maturities up to 397 days. Price Action XRP's price fluctuated between $2.264 and $2.319, representing a 2.37% range that highlights ongoing uncertainty. The token established a high-volume support zone at $2.273-$2.280, where buyers consistently emerged, stabilizing price action despite repeated tests of lower levels. Resistance formed at $2.315, where price rejections occurred during the 11th and 22nd hours, accompanied by above-average volume. In the final hour of trading, XRP experienced a sharp 2.17% decline at 01:55, dropping from $2.285 to $2.280. However, substantial buying volume of 3.9 million units emerged, reinforcing the $2.280 floor. The 01:32 candle showed the highest volume of the session at 1.8 million, confirming buyer interest at lower levels. An ascending support trendline suggests short-term stabilization, with traders eyeing potential breakout scenarios if resistance at $2.315 can be breached. Technical Analysis Recap XRP traded between $2.264 and $2.319, a 2.37% range. High-volume support zone established at $2.273-$2.280, with consistent buyer interest. Resistance formed at $2.315, with multiple price rejections and above-average volume. XRP closed at $2.284, signaling consolidation near the middle of the range. Sharp 2.17% decline at 01:55 (from $2.285 to $2.280) on increased volume. Highest volume observed at 01:32 (1.8M), confirming buyer support at lower levels. Ascending support trendline suggests short-term stabilization and potential breakout if resistance is breached.
Yahoo
26 minutes ago
- Yahoo
From AI to aerospace: Europe's most innovative companies shaping tomorrow
What does innovation look like in 2025? From AI to blockbuster weight-loss drugs, Europe's forward-thinking companies punch above their weight. For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the standouts that are driving progress with success. Patent data was provided by LexisNexis Intellectual Property Solutions. The list features 300 companies across 21 countries and 16 industries, and a total of 168 of the companies are on the Fortune 500 Europe. Companies on the list have brought in just under $8 trillion in annual revenue. The U.K. has more companies on our list than any other country, followed by Germany and Switzerland. The top sectors are finance, followed by retail and industrials. Companies on the list have brought in just under $8 trillion in annual revenue. The list features 300 companies across 21 countries and 16 industries, and a total of 168 of the companies are on the Fortune 500 Europe. Companies on the list have brought in just under $8 trillion in annual revenue. The U.K. has more companies on our list than any other country, followed by Germany and Switzerland. The top sectors are finance, followed by retail and industrials. L'Oréal was ranked at the top of the list in 2025. 'We are immensely proud to be recognized by Fortune as Europe's most innovative company,' Nicolas Hieronimus, Chief Executive Officer of L'Oréal told Fortune. 'This prestigious recognition reinforces our conviction that innovation, fueled by science, technology, and creativity, is the best way to succeed on the world stage, but is also a testament to the incredible talent and dedication of our teams around the globe.' We've highlighted some of the standout companies from this year's list driving innovation across Europe. Household products Noted for: Product innovation Employees: 50,000–99,999Fortune 500 Europe rank: 91France L'Oréal invests more than €1 billion annually in research and innovation and boasts a team of over 4,000 researchers. This, in turn, helps the French company formulate new ingredients and develop new products. Earlier this year, L'Oréal launched a device called Cell BioPrint that will give people a detailed assessment of their skin and the products best suited for it. 'This prestigious recognition reinforces our conviction that innovation, fueled by science, technology, and creativity, is the best way to succeed on the world stage…' Nicolas Hieronimus, CEO, L'Oréal Household products Product innovationEmployees: >100,000F500 Europe rank: 49U.K. Unilever's innovations take different shapes and forms—from fast-action laundry liquid to paper-cup instant noodles. The London-based company has 20,000 patents and a team of 5,000 experts who design new products, aided by nearly €1 billion in annual investments. Unilever has also expanded its AI use to help customers find the best products and discover new ones backed by scientific data. Health careProduct innovationEmployees: 50,000–99,999F500 Europe rank: 210Netherlands Founded in 1891, Royal Philips is known for pioneering innovations in lighting, health care, and consumer electronics. Key breakthroughs include the first compact audio cassette, electric razors, and mercury-free light bulbs. Today, Philips leads in sustainable, health–focused technology, improving billions of lives globally. Health careInnovation cultureEmployees: 50,000–99,999F500 Europe rank: 104U.K. GSK's innovations were reflected in its bottom line in 2024. With the help of its Silicon Valley veteran technology chief, Shobie Ramakrishnan, GSK is also using AI to speed drug discovery and streamline its supply chains. Health careInnovation cultureEmployees: 50,000–99,999F500 Europe rank: 116Denmark Novo Nordisk is wasting little time in developing new obesity treatments that, until recently, made it Europe's most valuable company. In May, the FDA accepted Novo's application to sell an oral version of Wegovy; an approval decision is expected in Q4. Novo Nordisk's recent trials for CagriSema, a new, more effective weight-loss medication, could increase its appeal beyond the millions already using its drugs. Health careProcess innovationEmployees: 50,000–99,999F500 Europe rank: 125Ireland In 2024, Medtronic invested more than $2.7 billion in R&D and operated over 81 manufacturing sites. AI is used to customize patient care, ranging from personalized brain therapy to data-driven diabetes care. The use of robotic-assisted surgery (RAS) also helps enhance precision and control. RetailingProduct innovationEmployees: >100,000F500 Europe rank: 144France Whether with Ray-Ban Meta glasses or its latest audio-enhancing eyewear, EssilorLuxottica is always pioneering new technology. Nearly 1,000 researchers across 50 R&D sites supported by up to €350 million in investment help the Franco-Italian company stay ahead of trends. The company is also vertically integrated, allowing for better quality control globally. Click here to view the full list. This story was originally featured on
